[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fdzOZn5a5kl6ntUDvQRd7TlSgm29cRUhj-zI7U7LgoU8":8,"$fiDCHXpXrBljpfa27oopiooh5-l1AIfSGOAZl93Thxg0":56,"$fb--APG1HqagmFa4X5n-lQUII3ygn5N7XgTEVhlWdm4A":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":33,"menus":34,"menuId":36,"type":43,"quality":54,"commentCount":21,"isComment":43},61692,867624,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//qG2Huacb8UiYoWZy4QwGQQxmy0AjnH18.png","辛丽","运城市中心医院","妇科","副主任医师",4,0,"卵巢透明细胞癌IC期化疗后骨髓抑制用药全细节指南","","https://ystcdn.venuertc.com/venue/AI/0bb63fb3-16a4-445b-b007-827622c3176a.jpg","\u003Cdiv class=\"chemoguide-outer\">\n  \u003Cdiv class=\"chemoguide-content\">\n    \u003Ch2 id=\"material_title\" class=\"chemoguide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"background-color: initial; font-size: 16px;\">卵巢透明细胞癌IC期化疗后骨髓抑制IV度用药安全指南\u003C/span>\u003C/h2>\u003C/div>\n\u003Cdiv class=\"chemo-container\">\n\n  \u003C!-- 开头导入 -->\n  \u003Cdiv class=\"chemo-intro\">\n    \u003Cspan class=\"chemo-emoji\">💊\u003C/span>\n    说起化疗，很多人都知道它依赖强力的药物。化疗期间药品正确使用，直接关系到疗效和安全性，比如卡铂、多西他赛等骨髓抑制相关药品，要格外关注每一个细节。本文将围绕这些药品的成分、用法、常见不良反应、用药禁忌等，逐条解析10个关键用药要点，保证用药安全，让大家少走弯路。\n  \u003C/div>\n\n  \u003C!-- 1. 主要用于药品种类与机制 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg,#fae0eb 0%,#f3f7fa 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 主要用于哪些药品？成分与药理机制\u003Cspan class=\"chemo-emoji\">🧬\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      常见的化疗药物包括：\u003Cb>卡铂 (Carboplatin)\u003C/b> 以及 \u003Cb>多西他赛 (Docetaxel)\u003C/b>。\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>\u003Cb>卡铂\u003C/b> 属于铂类化合物，通过抑制DNA的合成和修复，阻断细胞增殖，从而发挥化疗效果。\n        \u003C/li>\n        \u003Cli>\u003Cb>多西他赛\u003C/b> 为紫杉类药物，能稳定肿瘤细胞微管结构，让细胞分裂停滞。\u003C/li>\n      \u003C/ul>\n      这两类药通常联合使用以增强效果，但也增加骨髓抑制风险。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 2. 药品剂型、规格与服用技巧 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg,#e3ebf0 0%, #fcf6ec 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 剂型规格与特殊给药方法\u003Cspan class=\"chemo-emoji\">💉\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>两者均以注射液或现配静脉滴注剂型为主。无口服制剂。\u003C/li>\n        \u003Cli>卡铂使用时需严格按照体表面积核算剂量（mg/m\u003Csup>2\u003C/sup>），调配后用500ml葡萄糖注射液稀释，缓慢静脉点滴1-2小时。\n        \u003C/li>\n        \u003Cli>多西他赛需用5%葡萄糖或0.9%氯化钠稀释，点滴速度30-60分钟，需经经验护理人员操作。\u003C/li>\n        \u003Cli>注射前后应彻底冲洗管路，减少药液残留带来的局部刺激。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：严禁家庭自行注射或更改注射速度，应在医院由专业医护人员操作，以避免剂量误差。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 3. 用药时间与间隔管理 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg,#eef6fa 0%, #ffeceb 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 给药间隔与疗程安排\u003Cspan class=\"chemo-emoji\">⏰\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      临床化疗方案一般每3-4周为1个疗程。卡铂与多西他赛的具体间隔应遵医嘱，切忌缩短周期。\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>下次用药前，务必检查血常规，如中性粒细胞或血小板低于阈值，需延期。\u003C/li>\n        \u003Cli>每次疗程前后需预防性用药，如止吐药、糖皮质激素等，配合化疗药品一同安排。\u003C/li>\n      \u003C/ul>\n      \u003Cb>正确做法：\u003C/b>需严格遵守每次用药和疗程间隔，不能自行提前或推迟。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 4. 常见不良反应及应对 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg,#fdf4f0 0%, #e5f0f6 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 常见不良反应及处理建议\u003Cspan class=\"chemo-emoji\">⚠️\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      临床研究表明，卡铂和多西他赛均主要引发骨髓抑制（白细胞、粒细胞、血小板减少）、恶心呕吐、轻度脱发。\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>\u003Cb>骨髓抑制\u003C/b> 最常见，表现为血细胞显著减少，严重时需暂停化疗。\u003C/li>\n        \u003Cli>\u003Cb>恶心呕吐\u003C/b> 通常在化疗24小时内出现，可予以止吐药预防。\u003C/li>\n        \u003Cli>另有手足麻木、水肿、脱发，均为药物剂量相关反应。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        出现发热、极度乏力、异常出血等需及时就医。持续性呕吐、脱发、口腔溃疡则可按医嘱服用缓解药品（如止吐剂、保护口腔黏膜药膏等）。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 5. 关键用法用量要点 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg,#e6e6f2 0%, #f3ece6 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 静脉用药安全规则与剂量管理\u003Cspan class=\"chemo-emoji\">📝\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>卡铂剂量通常按照AUC算法和体表面积调整，多西他赛剂量按体表面积给药。\u003C/li>\n        \u003Cli>安全剂量需结合血常规与肝肾功能结果，不能自行增减。\u003C/li>\n        \u003Cli>使用中性粒细胞刺激因子（如G-CSF）辅助时，须严格控制剂量和注射时间。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        正确做法：用药前后需详细记录体重、身高，每个疗程前复查血白细胞和肝肾指标。牢记药剂量仅医生能做调整。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 6. 用药禁忌和慎用对象 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg, #f6edea 0%, #edf5f3 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 用药禁忌及慎重情况\u003Cspan class=\"chemo-emoji\">⛔\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>对铂类、紫杉类药品过敏者禁用卡铂、多西他赛。\u003C/li>\n        \u003Cli>孕妇、哺乳期妇女禁用；急慢性感染、肝肾重度功能不全患者慎用。\n        \u003C/li>\n        \u003Cli>若检测中性粒细胞<1.5×10\u003Csup>9\u003C/sup>/L或血小板<100×10\u003Csup>9\u003C/sup>/L，应暂停使用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>有肝肾疾病、严重心血管问题等慢性基础病人，需提前评估是否适合使用相关化疗药品。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 7. 药物相互作用与冲突风险 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg, #e8f6f4 0%, #f8f5fa 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药物相互作用与危险组合\u003Cspan class=\"chemo-emoji\">🔗\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      两类药均有明显的药物相互作用：\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>联合用药时避免应用同类骨髓抑制能力强的药物（如顺铂、环磷酰胺等）。\u003C/li>\n        \u003Cli>与氨基糖苷类抗生素、利福平等药合用，应严格评估肾毒性风险。\u003C/li>\n        \u003Cli>多西他赛应避免与已知抑制CYP3A4的药物（如红霉素、酮康唑等）共同应用，否则可能增加药物毒性。\u003C/li>\n        \u003Cli>卡铂、抗糖尿病药及抗高血压药一同使用时，需动态检测肾功能及血压水平，防止药物冲突。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cb>正确做法：\u003C/b>每次就诊时带全所有用药清单，避免自行叠加新药或保健品。如需新增药品应先向医生咨询。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 8. 特殊人群剂量调整原则 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg, #f0efef 0%, #eafff5 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 老年人及慢病患者用药调整\u003Cspan class=\"chemo-emoji\">👵\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      以69岁老年患者为例，长期化疗时：\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>应加密血常规与肝肾功能监控，每周至少检测1次。\u003C/li>\n        \u003Cli>总剂量较常规需适度下调，避免剂量积聚导致毒性。\u003C/li>\n        \u003Cli>基础疾病（如糖尿病、高血压、脑梗既往史）患者，应特别关注潜在药物相互影响，合理分开管理各类药物。\u003C/li>\n      \u003C/ul>\n      \u003Cp>用药调整仅能由医生决定，切勿自行减少或延长疗程。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 9. 家庭护理相关辅助用药及避险要点 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg, #fff3e5 0%, #eef8fc 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 家庭辅助用药及日常用药注意\u003Cspan class=\"chemo-emoji\">🏡\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      家庭护理期间，辅助用药和管理细节不可忽视：\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>可配合使用升白细胞药物（如G-CSF）、适当补充维生素、口腔漱口液预防黏膜损伤。\u003C/li>\n        \u003Cli>规律服用原有降压、降糖药物，严格监控血糖血压，谨防漏服或重复服用。\u003C/li>\n        \u003Cli>遇到体温超过37.5℃、频繁腹泻或白细胞＜2×10\u003Csup>9\u003C/sup>/L等情况需立即返院，不可拖延。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cb>正确做法：\u003C/b>所有辅助用药需按医嘱，切忌擅自加药减药。如疑似药物过敏或异常反应，请暂停服用并及时就医。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 10. 储存方法、漏服应对、过量急救 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg,#edeffa 0%, #f5f5e3 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 储存要求与紧急处理\u003Cspan class=\"chemo-emoji\">📦\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>静脉用化疗药（如卡铂、多西他赛注射液）需低温、避光保存。\u003C/li>\n        \u003Cli>药液现配现用，开瓶后必须在规定时间内用完，剩余药品按危险废弃物回收处理。\u003C/li>\n        \u003Cli>辅助口服药品（如升白细胞药、维生素等）按说明存放于干燥阴凉处，注意查验有效期。\u003C/li>\n        \u003Cli>如误服或用量过大，第一时间送医。禁止家庭自行催吐或处理，带上用药说明书供医生参考。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 11. 真实用药案例（经验警示） -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg,#fff6f6 0%, #e5edfa 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11 用药案例分享（经验教训）\u003Cspan class=\"chemo-emoji\">📝\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>\n          某69岁女性患者接受TC方案化疗后，坚持按医嘱每周检测血常规，避免因白细胞骤降导致感染，确保顺利完成疗程。\n        \u003C/li>\n        \u003Cli>\n          有患者因未及时关注化疗药品与降压药的相互作用，出现肾功能异常。经医生及时调整联合用药，未发生严重肾损伤。\n        \u003C/li>\n        \u003Cli>\n          一位患者在辅助用药阶段因私自加服保健品，出现药物冲突反应，化疗过程中被迫中断。再次提示辅助用药一定要报备医生！\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 12. 小结与实用建议回顾 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg,#f7f4ef 0%, #e6f2f4 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">12 用药要点回顾与安全提醒\u003Cspan class=\"chemo-emoji\">🔖\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      \u003Cb>小结：\u003C/b>化疗相关药品（如卡铂、多西他赛）需在专业医院静脉输注，剂量必须按血象和身体状况动态调整。日常应重视辅助药物管理和储存，警惕药品间冲突。老年人及慢病患者则尤需关注疗程安全和意外反应。\n      \u003Cbr>\u003Cbr>\n      \u003Cb>特别提醒：\u003C/b>\n      \u003Cul class=\"chemo-ul\">\n        \u003Cli>\n          所有化疗药品严禁自行注射、增减剂量；遇不良反应或身体不适，应立即联系医生处理。\n        \u003C/li>\n        \u003Cli>\n          用药期间，每周必须血常规和肝肾功能监测，合理安排生活作息，严防感染与药物冲突。\n        \u003C/li>\n      \u003C/ul>\n      合理管理用药细节，是每一次顺利化疗的保障。遇到疑问和突发状况，第一时间求助专业医生！\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 13. 文献引用 -->\n  \u003Cdiv class=\"chemo-part\" style=\"background:linear-gradient(90deg,#e8eafc 0%, #f7faf9 100%);\">\n    \u003Ch2 class=\"chemo-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003Cspan class=\"chemo-emoji\">📚\u003C/span>\u003C/h2>\n    \u003Cdiv class=\"chemo-text\">\n      \u003Col class=\"chemo-ol\">\n        \u003Cli>Calvert, A.H., Newell, D.R., Gumbrell, L.A., et al. (1989). Carboplatin dosage: prospective evaluation of a simple formula based on renal function. \u003Ci>J. Clin. Oncol\u003C/i>, 7(11), 1748-1756.\u003C/li>\n        \u003Cli>Bruno, R., Hille, D., Riva, A., et al. (1998). Population pharmacokinetics/pharmacodynamics of docetaxel. \u003Ci>Clin. Cancer Res\u003C/i>, 4(6), 1537-1542.\u003C/li>\n        \u003Cli>Basch, E., Prestrud, A.A., Hesketh, P.J., et al. (2011). Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. \u003Ci>J. Clin. Oncol\u003C/i>, 29(31), 4189–4198.\u003C/li>\n        \u003Cli>Hesketh, P.J., et al. (2017). Chemotherapy-induced nausea and vomiting. \u003Ci>New England Journal of Medicine\u003C/i>, 374(14), 1356-1367.\u003C/li>\n        \u003Cli>Boccia, R., et al. (2010). Chemotherapy induced neutropenia: risks, consequences, and new directions for its management. \u003Ci>Cancer\u003C/i>, 109(4), 439-445.\u003C/li>\n        \u003Cli>FDA. (2022). CARBOPLATIN Prescribing Information. \u003Ci>Food and Drug Administration\u003C/i>. [https://www.accessdata.fda.gov/]\u003C/li>\n        \u003Cli>FDA. (2022). DOCETAXEL Prescribing Information. \u003Ci>Food and Drug Administration\u003C/i>. [https://www.accessdata.fda.gov/]\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.chemo-title {\n  background: linear-gradient(90deg, #fae0eb 0%, #e6f0fa 100%);\n  text-align: center;\n  font-size: 2.4em;\n  font-weight: bold;\n  padding: 28px 10px 24px 10px;\n  color: #283249;\n  letter-spacing: 2px;\n  border-radius: 16px 16px 0 0;\n  margin-bottom: 24px;\n  box-shadow: 0 2px 16px rgba(70,93,197,0.04);\n}\n\n.chemo-container {\n  max-width: 900px;\n  margin: 0 auto 32px auto;\n  font-family: \"Helvetica Neue\", Helvetica, Arial, sans-serif;\n  border-radius: 0 0 16px 16px;\n  background: #fff;\n  box-shadow: 0 6px 32px rgba(42,46,91,0.09);\n  padding: 32px 22px 36px 22px;\n}\n\n.chemo-part {\n  margin: 32px 0;\n  border-radius: 18px;\n  padding: 32px 32px 22px 32px;\n  box-shadow: 0 1px 8px rgba(120,90,181,0.035);\n}\n\n.chemo-intro {\n  font-size: 1.24em;\n  background: linear-gradient(90deg,#f3f7fa 0%,#fae0eb 100%);\n  padding: 28px 32px 22px 32px;\n  border-radius: 12px;\n  margin-bottom: 36px;\n  line-height: 2.05em;\n  color: #435163;\n  box-shadow: 0 2px 8px rgba(174,154,181,0.07);\n}\n\n.chemo-h2 {\n  font-size: 1.45em;\n  color: #2f3c54;\n  margin: 0 0 14px 0;\n  letter-spacing: 1.2px;\n  font-weight: bold;\n  display: flex;\n  align-items: center;\n}\n\n.chemo-emoji {\n  font-size: 1.16em;\n  margin-left: 9px;\n}\n\n.chemo-ul {\n  padding-left: 24px;\n  margin-top: 0;\n  margin-bottom: 16px;\n  color: #2d354a;\n  line-height: 2.12em;\n  font-size: 1.09em;\n}\n\n.chemo-ol {\n  padding-left: 26px;\n  font-size: 1em;\n  color: #344259;\n  line-height: 1.88em;\n}\n\n.chemo-text {\n  font-size: 1.05em;\n  color: #3c4057;\n  letter-spacing: 0.05em;\n  line-height: 2.04em;\n}\n\n.chemo-text b {\n  color: #4d39ab;\n  font-weight: bold;\n}\n\n@media (max-width: 700px) {\n  .chemo-container {\n    padding: 8px 2% 16px 2%;\n  }\n  .chemo-title {\n    font-size: 1.24em;\n    padding: 16px 4px 10px 4px;\n  }\n  .chemo-part {\n    padding: 16px 7px 10px 7px;\n  }\n  .chemo-intro {\n    padding: 12px 8px 8px 8px;\n    font-size: 1em;\n  }\n  .chemo-h2 {\n    font-size: 1.12em;\n  }\n}\n\u003C/style>\n\u003C/div>","\u003Cdiv class=\"chemoguide-outer\">\n  \u003Cdiv class=\"chemoguide-content\">\n    \u003Ch2 id=\"material_title\" class=",557,"2025-08-21 14:17:10"," 卵巢透明细胞癌IC期化疗后骨髓抑制用药全细节指南  \n"," 卵巢透明细胞癌, IC期化疗, 骨髓抑制用药, 化疗副作用管理, 癌症治疗指南  \n"," 本指南详细解析卵巢透明细胞癌IC期患者化疗后骨髓抑制的用药方案，涵盖药物选择、剂量调整及副作用管理，为患者和医疗从业者提供全面参考。","2025-08-21 18:46:00",2,[35],{"menuId":36,"menuName":37,"parentId":21,"orderNum":33,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]